Researcher at the Environmental Health Sciences Research Center
Engineering and Pharmacy
When patients with cystic fibrosis or other disorders that weaken the immune system are infected with bacteria like Pseudomonas aeruginosa, it can lead to ongoing, decades-long infections and even death. That’s why Jennifer Fiegel is researching ways to develop more effective, inhalable treatments for respiratory infections. With a research award from the National Institutes of Health, Fiegel hopes to identify a unique combination of compounds to more effectively eradicate P. aeruginosa, and her team’s preliminary results already show success working on a simple strain of the bacteria in the lab as well as clinical isolates from patients with cystic fibrosis.
Banner location: not on display—